How much is the estimated financial impact of this charge on 3M?

The estimated impact is a one-time, non-cash charge of approximately $85 million to $90 million after tax. This is expected to reduce earnings per share by about 12 cents.

Will this charge affect 3M's ongoing business operations or future profitability?

This is a one-time, non-cash accounting charge related to a specific tax subsidy. It does not directly impact 3M's ongoing operational cash flows or the fundamental profitability of its core businesses. However, it will reduce reported GAAP earnings for the first quarter of 2010.

How will investors see this charge reflected in 3M's financial reporting?

3M has stated that it will report both its standard GAAP earnings and its earnings excluding this one-time special item in its first-quarter 2010 earnings release. This will allow investors to better understand the underlying performance of the business without the impact of this specific legislative change.

MMM 8-K SEC Disclosure — Mar 26, 2010

Q: What is the primary reason for the one-time charge disclosed in this 8-K?

The one-time charge is due to the Patient Protection and Affordable Care Act (ACA) and its related modifications, which eliminate a tax-advantaged subsidy that 3M received for providing retiree prescription drug coverage. Although the subsidy elimination is effective in 2013, accounting regulations require the recognition of its impact in the period the law is enacted.

Summary

This 8-K filing from 3M Company on March 26, 2010, discloses a significant financial event related to the recently enacted Patient Protection and Affordable Care Act (ACA) and its modifications. The Act eliminates a tax-advantaged subsidy that 3M, along with other companies, received for providing retiree prescription drug coverage. While the elimination of this subsidy officially takes effect in 2013, accounting rules require 3M to recognize the full impact in its first quarter 2010 financial statements. As a result, 3M will incur a one-time, non-cash charge estimated to be between $85 million and $90 million after tax, translating to approximately 12 cents per share. This charge reflects a reduction in the value of the company's deferred tax asset related to the subsidy. 3M has indicated that its previously issued 2010 GAAP earnings expectations did not account for this new legislation and that its first-quarter 2010 earnings release will provide both GAAP and adjusted earnings figures, excluding this special item.

Key Highlights

13M to record a one-time, non-cash charge of approximately $85-$90 million after tax in Q1 2010.
2The charge is a direct result of the Patient Protection and Affordable Care Act (ACA) and related legislative modifications.
3The ACA eliminates a tax-advantaged subsidy previously received by 3M for retiree prescription drug coverage.
4Although the subsidy's elimination is effective in 2013, accounting rules necessitate recognizing the impact immediately upon enactment of the law.
5The charge will reduce the value of 3M's deferred tax asset related to the subsidy.
6The estimated impact on earnings per share is approximately 12 cents.
73M will report both GAAP and adjusted earnings (excluding this charge) in its Q1 2010 earnings release.

3M CO 8-K Report, Corporate Update (Mar 26, 2010)

Summary

Key Highlights

Frequently Asked Questions